Ost-müük Clover Health Investments - CLOV CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.0196 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.030779% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.013666% | ||||||||
Ööpäeva tasu aeg | 22:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 1.2751 |
Avatud* | 1.2751 |
Aastane muutus* | -50.58% |
Päeva ulatus* | 1.2252 - 1.2751 |
52 nädala ulatus | 0.86-3.90 |
Keskmine maht (10 päeva) | 6.79M |
Keskmine maht (3 kuud) | 133.16M |
Turukapitalisatsioon | 616.55M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 477.94M |
Tulu | 3.01B |
EPS | -0.98 |
Dividendid (% kasumist) | N/A |
Beeta | -100.00K |
Järgmine tuluaruande kuupäev | Feb 28, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Feb 8, 2023 | 1.2452 | -0.0098 | -0.78% | 1.2550 | 1.2950 | 1.2252 |
Feb 7, 2023 | 1.2751 | 0.0499 | 4.07% | 1.2252 | 1.2850 | 1.1953 |
Feb 6, 2023 | 1.2252 | -0.0299 | -2.38% | 1.2551 | 1.2850 | 1.2153 |
Feb 3, 2023 | 1.2751 | 0.0100 | 0.79% | 1.2651 | 1.3249 | 1.2352 |
Feb 2, 2023 | 1.2850 | -0.0697 | -5.15% | 1.3547 | 1.4345 | 1.2850 |
Feb 1, 2023 | 1.3348 | 0.0199 | 1.51% | 1.3149 | 1.3548 | 1.2551 |
Jan 31, 2023 | 1.3149 | 0.1196 | 10.01% | 1.1953 | 1.3647 | 1.1953 |
Jan 30, 2023 | 1.2053 | 0.0000 | 0.00% | 1.2053 | 1.2551 | 1.1954 |
Jan 27, 2023 | 1.2452 | 0.0897 | 7.76% | 1.1555 | 1.2551 | 1.1554 |
Jan 26, 2023 | 1.1854 | -0.0299 | -2.46% | 1.2153 | 1.2352 | 1.1655 |
Jan 25, 2023 | 1.1954 | 0.0100 | 0.84% | 1.1854 | 1.2053 | 1.1555 |
Jan 24, 2023 | 1.2053 | -0.0299 | -2.42% | 1.2352 | 1.2751 | 1.1854 |
Jan 23, 2023 | 1.2651 | 0.0199 | 1.60% | 1.2452 | 1.2751 | 1.2252 |
Jan 20, 2023 | 1.2452 | 0.0499 | 4.17% | 1.1953 | 1.2551 | 1.1555 |
Jan 19, 2023 | 1.1754 | -0.0299 | -2.48% | 1.2053 | 1.2153 | 1.1555 |
Jan 18, 2023 | 1.2153 | -0.0497 | -3.93% | 1.2650 | 1.2950 | 1.2153 |
Jan 17, 2023 | 1.2452 | 0.0100 | 0.81% | 1.2352 | 1.2651 | 1.1953 |
Jan 13, 2023 | 1.2252 | 0.0298 | 2.49% | 1.1954 | 1.2751 | 1.1953 |
Jan 12, 2023 | 1.2252 | 0.0398 | 3.36% | 1.1854 | 1.2252 | 1.1256 |
Jan 11, 2023 | 1.1555 | -0.0199 | -1.69% | 1.1754 | 1.2053 | 1.0957 |
Clover Health Investments Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2019 | 2020 | 2021 | |
---|---|---|---|
Kogutulu | 0 | 0 | 1472 |
Kogu tegevuskulu | 0.01763 | 6.8621 | 2108.99 |
Other Operating Expenses, Total | 0.01763 | 6.8621 | 1662 |
Tulud majandustegevusest | -0.01763 | -6.8621 | -636.992 |
Netotulu enne makse | -0.01763 | -6.74484 | -587.756 |
Netotulu pärast makse | -0.01763 | -6.74484 | -587.756 |
Netotulu enne erikulusid | -0.01763 | -6.74484 | -587.756 |
Netotulu | -0.01763 | -6.74484 | -587.756 |
Arvestatav tulu, v a erikulud | -0.01763 | -6.74484 | -587.756 |
Arvestatav tulu, koos erikuludega | -0.01763 | -6.74484 | -587.756 |
Jaotamisele kuuluv netotulu | -0.01763 | -6.74484 | -587.756 |
Keskmine jaotamisele kuuluv aktsia kohta | 75 | 103.5 | 412.922 |
Jaotatav EPS, v a erakorralised kulud | -0.00024 | -0.06517 | -1.42341 |
Dividends per Share - Common Stock Primary Issue | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.00024 | -0.06517 | -1.42341 |
Intressitulud (kulu), muud tulud, neto | 0.11726 | 62.917 | |
Tulu | 1472 | ||
Müük/Üldine/admin kulud, kokku | 445.745 | ||
Depreciation / Amortization | 1.246 | ||
Muud, neto | -13.681 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kogutulu | 200.325 | 412.472 | 427.163 | 432.036 | 874.379 |
Tulu | 200.325 | 412.472 | 427.163 | 432.036 | 874.379 |
Kogu tegevuskulu | 319.413 | 594.334 | 576.416 | 618.825 | 961.679 |
Müük/Üldine/admin kulud, kokku | 104.63 | 107.795 | 119.113 | 114.207 | 126.788 |
Depreciation / Amortization | 0.16 | 0.118 | 0.12 | 0.848 | 0.826 |
Other Operating Expenses, Total | 214.623 | 486.421 | 457.183 | 503.77 | 834.065 |
Tulud majandustegevusest | -119.088 | -181.862 | -149.253 | -186.789 | -87.3 |
Intressitulud (kulu), muud tulud, neto | 84.331 | -135.741 | 114.739 | -0.412 | 11.991 |
Muud, neto | -13.66 | -0.008 | -0.013 | 0 | 0 |
Netotulu enne makse | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Netotulu pärast makse | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Netotulu enne erikulusid | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Netotulu | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Arvestatav tulu, v a erikulud | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Arvestatav tulu, koos erikuludega | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Jaotamisele kuuluv netotulu | -48.417 | -317.611 | -34.527 | -187.201 | -75.309 |
Keskmine jaotamisele kuuluv aktsia kohta | 376.171 | 408.157 | 414.573 | 420.437 | 473.029 |
Jaotatav EPS, v a erakorralised kulud | -0.12871 | -0.77816 | -0.08328 | -0.44525 | -0.15921 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.12871 | -0.77816 | -0.08328 | -0.44525 | -0.15921 |
- Aastas
- Kvartalis
2019 | 2020 | 2021 | |
---|---|---|---|
Käibevarad kokku | 0 | 28.3029 | 752.546 |
Raha ja lühiajalised investeeringud | 0 | 28.0032 | 627.868 |
Cash | 0 | 28.0032 | |
Total Assets | 0.10035 | 856.42 | 950.804 |
Other Long Term Assets, Total | 0.10035 | 0 | 10.432 |
Total Current Liabilities | 0.11798 | 33.934 | 372.624 |
Accrued Expenses | 0.11798 | 5.12778 | 18.206 |
Notes Payable/Short Term Debt | 0 | 0.80621 | 0 |
Total Liabilities | 0.11798 | 62.914 | 415.39 |
Total Long Term Debt | 0 | 0 | 19.938 |
Total Equity | -0.01763 | 793.506 | 535.414 |
Common Stock | 0 | 788.509 | 0.046 |
Additional Paid-In Capital | 0 | 11.76 | 2154.19 |
Retained Earnings (Accumulated Deficit) | -0.01763 | -6.76247 | -1616.74 |
Total Liabilities & Shareholders’ Equity | 0.10035 | 856.42 | 950.804 |
Total Common Shares Outstanding | 75 | 103.5 | 470.838 |
Prepaid Expenses | 0.29967 | 9.409 | |
Long Term Investments | 828.117 | 175.939 | |
Other Current Liabilities, Total | 28 | 326.289 | |
Other Liabilities, Total | 28.98 | 18.925 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |
Raha ja ekvivalendid | 299.968 | ||
Lühiajalised investeeringud | 327.9 | ||
Laekumata arved, neto | 62.324 | ||
Other Current Assets, Total | 52.945 | ||
Property/Plant/Equipment, Total - Net | 7.654 | ||
Property/Plant/Equipment, Total - Gross | 9.966 | ||
Accumulated Depreciation, Total | -2.312 | ||
Intangibles, Net | 4.233 | ||
Payable/Accrued | 28.129 | ||
Long Term Debt | 19.938 | ||
Minority Interest | 3.903 | ||
Treasury Stock - Common | -0.147 | ||
Other Equity, Total | -1.934 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 809.449 | 717.714 | 559.281 | 752.546 | 2491.42 |
Raha ja lühiajalised investeeringud | 684.574 | 607.145 | 455.266 | 627.868 | 578.564 |
Raha ja ekvivalendid | 404.507 | 485.747 | 202.264 | 299.968 | 273.831 |
Lühiajalised investeeringud | 280.067 | 121.398 | 253.002 | 327.9 | 304.733 |
Laekumata arved, neto | 49.436 | 55.515 | 55.783 | 62.324 | 1816.05 |
Other Current Assets, Total | 75.439 | 40.519 | 36.055 | 52.945 | 74.862 |
Total Assets | 866.942 | 1215.9 | 952.478 | 950.804 | 2679.89 |
Property/Plant/Equipment, Total - Net | 9.126 | 8.457 | 8 | 7.654 | 7.311 |
Intangibles, Net | 4.233 | 4.233 | 4.233 | 4.233 | 4.233 |
Long Term Investments | 35.493 | 38.684 | 146.573 | 175.939 | 162.226 |
Other Long Term Assets, Total | 8.641 | 10.475 | 13.653 | 10.432 | 14.707 |
Total Current Liabilities | 173.025 | 195.897 | 230.249 | 372.624 | 2152.02 |
Payable/Accrued | 18.32 | 20.844 | 24.208 | 28.129 | 27.451 |
Accrued Expenses | 15.693 | 14.596 | 17.165 | 18.206 | 14.001 |
Notes Payable/Short Term Debt | 21.425 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 117.587 | 160.457 | 188.876 | 326.289 | 2110.57 |
Total Liabilities | 281.91 | 904.945 | 544.091 | 415.39 | 2190.08 |
Total Long Term Debt | 24.285 | 19.852 | 19.929 | 19.938 | 19.947 |
Long Term Debt | 24.285 | 19.852 | 19.929 | 19.938 | 19.947 |
Minority Interest | 3.903 | 3.903 | 3.903 | 3.903 | 0 |
Other Liabilities, Total | 80.697 | 685.293 | 290.01 | 18.925 | 18.111 |
Total Equity | 585.032 | 310.952 | 408.387 | 535.414 | 489.813 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.041 | 0.041 | 0.042 | 0.046 | 0.046 |
Additional Paid-In Capital | 1662.87 | 1706.33 | 1838.64 | 2154.19 | 2195.16 |
Retained Earnings (Accumulated Deficit) | -1077.4 | -1395.01 | -1429.54 | -1616.74 | -1692.05 |
Other Equity, Total | -0.483 | -0.413 | -0.61 | -1.934 | -7.258 |
Total Liabilities & Shareholders’ Equity | 866.942 | 1215.9 | 952.478 | 950.804 | 2679.89 |
Total Common Shares Outstanding | 408.101 | 408.305 | 420.613 | 470.838 | 471.409 |
Prepaid Expenses | 14.535 | 12.177 | 9.409 | 21.937 | |
Note Receivable - Long Term | 436.334 | 220.738 | |||
Treasury Stock - Common | -0.147 | -0.147 | -6.086 |
- Aastas
- Kvartalis
2019 | 2020 | 2021 | |
---|---|---|---|
Netotulu/algväärtus | -0.01763 | -6.74484 | -587.756 |
Raha majandustegevusest | -0.01763 | -2.22712 | -282.326 |
Rahavood investeeringutelt | 0.01763 | 858.23 | 925.393 |
Rahavoogudesse investeerimine | 0.01763 | -0.77635 | 666.241 |
Aktsiate emiteerimine (tagasiost), neto | 0 | 830.025 | 290.077 |
Laenu väljastamine (kustutamine), neto | 0 | 28.9817 | -30.925 |
Rahaline kogumuutus | 0 | 28.0032 | 207.62 |
Mittelikviidsed varad | -0.11726 | 111.511 | |
Muutused tööjõus | 4.63498 | 192.673 | |
Tulu investeeringutelt | -828 | -435.447 | |
Muud rahavood investeeringutelt, kokku | -828 | -434.724 | |
Raha majandustegevusest | 1.246 | ||
Kapitalikulutused | -0.723 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -48.417 | -366.028 | -400.555 | -587.756 | -75.309 |
Cash From Operating Activities | -92.869 | -157.024 | -202.15 | -282.326 | -57.042 |
Cash From Operating Activities | 0.16 | 0.278 | 0.398 | 1.246 | 0.826 |
Non-Cash Items | -29.005 | 148.563 | 80.271 | 111.511 | 28.229 |
Changes in Working Capital | -15.607 | 60.163 | 117.736 | 192.673 | -10.788 |
Cash From Investing Activities | -257.476 | -86.611 | -328.956 | -435.447 | 36.513 |
Capital Expenditures | -0.099 | -0.29 | -0.485 | -0.723 | -0.158 |
Other Investing Cash Flow Items, Total | -257.377 | -86.321 | -328.471 | -434.724 | 36.671 |
Cash From Financing Activities | 662.504 | 637.034 | 641.022 | 925.393 | -5.608 |
Financing Cash Flow Items | 666.242 | 666.242 | 666.242 | 666.241 | 0 |
Issuance (Retirement) of Stock, Net | 1.282 | 1.717 | 5.705 | 290.077 | -5.608 |
Issuance (Retirement) of Debt, Net | -5.02 | -30.925 | -30.925 | -30.925 | 0 |
Net Change in Cash | 312.159 | 393.399 | 109.916 | 207.62 | -26.137 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.0461 | 30860594 | -1184945 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.7711 | 22134837 | 479993 | 2022-09-30 | LOW |
ChaChaCha SPAC C, LLC. | Corporation | 4.9883 | 19132693 | -9275787 | 2022-10-03 | LOW |
Toy (Andrew) | Individual Investor | 3.2407 | 12429585 | 9734513 | 2023-01-01 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.1264 | 8155795 | 205043 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6326 | 6261925 | 238217 | 2022-09-30 | LOW |
PNC Wealth Management | Investment Advisor | 1.5274 | 5858196 | -350183 | 2022-09-30 | LOW |
Leffler (Scott J.) | Individual Investor | 1.3172 | 5052016 | 5052016 | 2022-07-25 | LOW |
Osborne (Ian) | Individual Investor | 1.0596 | 4063919 | -936081 | 2021-11-22 | |
Renaissance Technologies LLC | Hedge Fund | 1.0379 | 3980700 | 2351160 | 2022-09-30 | HIGH |
Martin (Joseph Richards) | Individual Investor | 0.8084 | 3100775 | 3100775 | 2022-03-14 | |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7839 | 3006494 | -125657 | 2022-09-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.6897 | 2645503 | 0 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6554 | 2513873 | 169657 | 2022-09-30 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.6492 | 2490149 | 5561 | 2022-09-30 | LOW |
Jupiter Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.6166 | 2365118 | -297863 | 2022-09-30 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.5558 | 2131588 | 404578 | 2022-09-30 | HIGH |
Hudson Structured Capital Management Ltd. | Hedge Fund | 0.5147 | 1973944 | 0 | 2022-12-31 | LOW |
Nuveen LLC | Pension Fund | 0.4641 | 1780071 | 474829 | 2022-09-30 | LOW |
Palihapitiya (Chamath) | Individual Investor | 0.4534 | 1739130 | 1739130 | 2021-11-22 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com GroupKauplejad
Igakuiste aktiivsete klientide arv
Igakuine investeerimise maht
Igakuiselt välja võetud
Kauplemiskalkulaator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Clover Health Investments Company profile
Ettevõttest Clover Health Investments
Clover Health Investments, Corp. on tervishoiutehnoloogia ettevõte. Ettevõtte segmentide hulka kuuluvad Medicare Advantage (MA) ja Direct Contracting (DC). MA-segment on kindlustuse ärimudel, mis keskendub Clover Assistant'i kasutamisele ravipunktis. Ettevõtte DC-segment on sarnane kulude juhtimise ja hoolduse koordineerimise mudeliga, mida arvestatakse tulemuslikkuse garantiina, kus Clover vastutab hoolduse koordineerimise, kulude haldamise ja teenuseosutajate ja nende otsese lepingupartneri (DCE) abisaajate toetamise eest Clover Assistant'i kasutamise kaudu. See pakub tarkvaraplatvormi nimega Clover Assistant, mis pakub Ameerika eakatele eelistatud teenuseosutajaorganisatsiooni (PPO) ja tervishoiuteenuste säilitamise organisatsiooni (HMO) plaane, mis on Medicare'ile kõlblike tarbijate jaoks ilmselge valik. Clover Assistant on tehnoloogiaplatvorm, mis kaasab teenuseosutajaid ning pakub andmepõhist ja isikupärastatud hooldust. See haldab oma MA-kavasid enam kui üheksas osariigis.
Industry: | Medical Software & Technology Services |
3401 Mallory Lane, Suite 210
Suite 320
FRANKLIN
TENNESSEE 37067
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com